In this paper, using two models of diabetes, we demonstrated that FGF21 ameliorates proteinuria, oxidative stress and inflammation, as well as fibrosis and glomerular podocyte loss or swelling, and impaired glomerular filtration barrier in mice with diabetic nephropathy. The gene discussed is FGF21; the disease is diabetic kidney disease.